Hepatitis B/C and HIV in sub-Saharan Africa: An association between highly prevalent infectious diseases. A systematic review and meta-analysis
dc.contributor.author | Barth R.E. | |
dc.contributor.author | Huijgen Q. | |
dc.contributor.author | Taljaard J. | |
dc.contributor.author | Hoepelman A.I.M. | |
dc.date.accessioned | 2011-05-15T16:16:44Z | |
dc.date.available | 2011-05-15T16:16:44Z | |
dc.date.issued | 2010 | |
dc.description.abstract | Objectives: Hepatitis B virus (HBV), hepatitis C virus (HCV), and the human immunodeficiency virus (HIV) are endemic in Africa. However, hepatitis co-infection rates among HIV-infected individuals remain controversial. The aim of this review was to determine the prevalence of HBV and HCV in HIV-infected patients in sub-Saharan Africa and to analyze whether HIV is associated with a higher HBV/HCV prevalence in that region. Design and methods: We performed a systematic review and meta-analysis. Studies reporting HBV and HCV prevalence data amongst HIV-infected patients in sub-Saharan Africa were included. Weighted means and medians across studies were calculated. Studies including an HIV-negative control group were used for meta-analysis. Risk ratios (RRs) were calculated using a random effects model. Results: Sixty studies were included. Among HIV-infected individuals, mean HBsAg and anti-HCV prevalence rates were 15% and 7%, respectively. RRs for a positive HBsAg and a positive anti-HCV were 1.40 (95% confidence interval (CI) 1.16-1.69) and 1.60 (95% CI 1.05-2.45) for HIV-infected, as compared to HIV-uninfected, patients. Conclusions: Many HIV-positive individuals in sub-Saharan Africa are HBV or HCV co-infected. HIV is associated with a higher prevalence of both HBV and HCV in this region. However, this association is less evident than that observed in Western countries and varies between studies. © 2010 International Society for Infectious Diseases. | |
dc.description.version | Review | |
dc.identifier.citation | International Journal of Infectious Diseases | |
dc.identifier.citation | 14 | |
dc.identifier.citation | 12 | |
dc.identifier.issn | 12019712 | |
dc.identifier.other | 10.1016/j.ijid.2010.06.013 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/13909 | |
dc.subject | hepatitis B antigen | |
dc.subject | hepatitis C antigen | |
dc.subject | Africa | |
dc.subject | disease association | |
dc.subject | hepatitis B | |
dc.subject | hepatitis C | |
dc.subject | high risk population | |
dc.subject | human | |
dc.subject | Human immunodeficiency virus infected patient | |
dc.subject | Human immunodeficiency virus infection | |
dc.subject | meta analysis | |
dc.subject | mixed infection | |
dc.subject | prevalence | |
dc.subject | review | |
dc.subject | risk assessment | |
dc.subject | systematic review | |
dc.subject | Africa South of the Sahara | |
dc.subject | Hepacivirus | |
dc.subject | Hepatitis B | |
dc.subject | Hepatitis B virus | |
dc.subject | Hepatitis C | |
dc.subject | HIV Infections | |
dc.subject | HIV-1 | |
dc.subject | Humans | |
dc.subject | Prevalence | |
dc.title | Hepatitis B/C and HIV in sub-Saharan Africa: An association between highly prevalent infectious diseases. A systematic review and meta-analysis | |
dc.type | Review |